Sign up to save your podcasts
Or
Share Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37
In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem.
Episode 37 links:
View all episodes
By Genialis
4.7
77 ratings
In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem.
Episode 37 links:
More shows like Talking Precision Medicine
View all
Science Weekly
418 Listeners
Freakonomics Radio
32,165 Listeners
TED Radio Hour
21,953 Listeners
Hidden Brain
43,708 Listeners
Pivot
9,562 Listeners
The Daily
112,467 Listeners
The Journal.
6,013 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,808 Listeners
BioCentury This Week
32 Listeners
Biotech Hangout
20 Listeners